BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Berman RM, Kelada OJ, Gutsche NT, Natarajan R, Swenson RE, Fu Y, Hong J, Ho M, Choyke PL, Escorcia FE. In Vitro Performance of Published Glypican 3-Targeting Peptides TJ12P1 and L5 Indicates Lack of Specificity and Potency. Cancer Biother Radiopharm 2019;34:498-503. [PMID: 31424293 DOI: 10.1089/cbr.2019.2888] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 An S, Zhang D, Zhang Y, Wang C, Shi L, Wei W, Huang G, Liu J. GPC3-targeted immunoPET imaging of hepatocellular carcinomas. Eur J Nucl Med Mol Imaging 2022. [PMID: 35147737 DOI: 10.1007/s00259-022-05723-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
2 Klika KD, Da Pieve C, Kopka K, Smith G, Makarem A. Synthesis and application of a thiol-reactive HBED-type chelator for development of easy-to-produce Ga-radiopharmaceutical kits and imaging probes. Org Biomol Chem 2021;19:1722-6. [PMID: 33527964 DOI: 10.1039/d0ob02513e] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Bell MM, Gutsche NT, King AP, Baidoo KE, Kelada OJ, Choyke PL, Escorcia FE. Glypican-3-Targeted Alpha Particle Therapy for Hepatocellular Carcinoma. Molecules 2020;26:E4. [PMID: 33374953 DOI: 10.3390/molecules26010004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
4 [DOI: 10.1101/2020.01.31.926972] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]